ClearPoint Neuro (CLPT) Capital Expenditures (2011 - 2026)
ClearPoint Neuro (CLPT) reported Capital Expenditures of $645000.0 for Q1 2026, up 252.46% on a YoY basis from $183000.0 in Q1 2025, and up 1216.33% sequentially from $49000.0 in Q4 2025.
ClearPoint Neuro (CLPT) Capital Expenditures (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 14 years of Capital Expenditures data on file, last reported at $645000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 252.46% year-over-year to $645000.0; the trailing twelve-month figure through Mar 2026 stood at $984000.0 (up 114.85% YoY), and the FY2025 full-year result was $522000.0, up 89.82% from the prior year.
- Capital Expenditures grew to $645000.0 in Q1 2026, from $49000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $645000.0 in Q1 2026 to a low of $12000.0 in Q3 2024.
- A 5-year average of $160800.0 and a median of $91000.0 in 2025 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures plunged 94.89% in 2024 and jumped 1558.33% in 2025, its largest moves.
- Tracing CLPT's Capital Expenditures over 5 years: stood at $39000.0 in 2022, then sank by 46.15% to $21000.0 in 2023, then jumped by 1152.38% to $263000.0 in 2024, then tumbled by 81.37% to $49000.0 in 2025, then soared by 1216.33% to $645000.0 in 2026.
- Business Quant data shows CLPT's Capital Expenditures at $645000.0 in Q1 2026, $49000.0 in Q4 2025, and $199000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | 645,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 645,000.00 |
| Mar 31, 2026 | 645,000.00 |
| Dec 31, 2025 | 49,000.00 |
| Dec 31, 2025 | 49,000.00 |
| Sep 30, 2025 | 199,000.00 |
| Sep 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 91,000.00 |
| Jun 30, 2025 | 91,000.00 |
| Mar 31, 2025 | 183,000.00 |
| Mar 31, 2025 | 183,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Sep 30, 2023 | 235,000.00 |
| Sep 30, 2023 | 235,000.00 |
| Jun 30, 2023 | 323,000.00 |
| Jun 30, 2023 | 323,000.00 |